MATINAS BIOPHARMA HLDGS INC - COM (MTNB)

CUSIP: 576810105

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM
Total 13F shares
27,870,177
Share change
+708,265
Total reported value
$17,966,158
Price per share
$0.64
Number of holders
49
Value change
+$449,589
Number of buys
16
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 576810105?
CUSIP 576810105 identifies MTNB - MATINAS BIOPHARMA HLDGS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MATINAS BIOPHARMA HLDGS INC - COM (MTNB) as of Q3 2022

As of 30 Sep 2022, MATINAS BIOPHARMA HLDGS INC - COM (MTNB) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,870,177 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Sargent Investment Group, LLC, NEVILLE RODIE & SHAW INC, GEODE CAPITAL MANAGEMENT, LLC, Arkadios Wealth Advisors, JTC Employer Solutions Trustee Ltd, BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and LPL Financial LLC. This page lists 49 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.